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Abstract
Background: During infection, Mycobacterium tuberculosis confronts a generally hostile and nutrient-poor in vivo
host environment. Existing models and analyses of M. tuberculosis metabolic networks are able to reproduce
experimentally measured cellular growth rates and identify genes required for growth in a range of different in
vitro media. However, these models, under in vitro conditions, do not provide an adequate description of the
metabolic processes required by the pathogen to infect and persist in a host.
Results: To better account for the metabolic activity of M. tuberculosis in the host environment, we developed a
set of procedures to systematically modify an existing in vitro metabolic network by enhancing the agreement
between calculated and in vivo-measured gene essentiality data. After our modifications, the new in vivo network
contained 663 genes, 838 metabolites, and 1,049 reactions and had a significantly increased sensitivity (0.81) in
predicted gene essentiality than the in vitro network (0.31). We verified the modifications generated from the
purely computational analysis through a review of the literature and found, for example, that, as the analysis
suggested, lipids are used as the main source for carbon metabolism and oxygen must be available for the
pathogen under in vivo conditions. Moreover, we used the developed in vivo network to predict the effects of
double-gene deletions on M. tuberculosis growth in the host environment, explore metabolic adaptations to life in
an acidic environment, highlight the importance of different enzymes in the tricarboxylic acid-cycle under different
limiting nutrient conditions, investigate the effects of inhibiting multiple reactions, and look at the importance of
both aerobic and anaerobic cellular respiration during infection.
Conclusions: The network modifications we implemented suggest a distinctive set of metabolic conditions and
requirements faced by M. tuberculosis during host infection compared with in vitro growth. Likewise, the double-
gene deletion calculations highlight the importance of specific metabolic pathways used by the pathogen in the
host environment. The newly constructed network provides a quantitative model to study the metabolism and
associated drug targets of M. tuberculosis under in vivo conditions.
Background
Tuberculosis (TB) continues to be a major health threat,
with 9.2 million new cases and 1.7 million deaths
reported worldwide in 2006 [1,2]. It has been estimated
that one-third of the human population is infected with
Mycobacterium tuberculosis, the causative agent of TB
[3]. Worldwide efforts to treat and eliminate TB are
confronting many obstacles, including drug-resistant
bacterial strains, lack of compliance with the compli-
cated drug regimens, and an increased patient popula-
tion with compromised immune systems associated with
acquired immunodeficiency syndrome [3,4].
In general, bacterial metabolism is an attractive drug
target for two main reasons: 1) metabolism is required
for the bacterium to sustain itself and 2) many bacterial
metabolic targets are absent in humans. Novel efforts in
developing drugs that target the intracellular metabolism
of M. tuberculosis often focus on metabolic pathways
that are specific to M. tuberculosis [5,6]. However, TB is
a complex disease caused by bacterial populations
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access to a varying availability of nutrients [7]. This,
coupled with the differences in bacterial metabolism
under in vivo and in vitro conditions [8-10], creates a
challenge in modeling and understanding the metabolic
requirements of M. tuberculosis inside a host.
Recently, genome-scale metabolic network reconstruc-
tions for different organisms have enabled systematic
analyses of metabolic functions and predictions of meta-
bolism-related phenotypes [11,12]. By collecting all pos-
sible biochemical reactions for specific organisms,
different groups have reconstructed metabolic networks
for bacteria (e.g., for Escherichia coli [13], Helicobacter
pylori [14], and M. tuberculosis [15,16]), eukaryotic
microorganisms [17-19], mice [20], and even humans
[21]. The Web site of the Systems Biology Research
Group at the University of California, San Diego, pro-
vides a continuously updated list of genome-scale meta-
bolic network reconstructions [22]. Analysis of
metabolic networks can provide insights into an organ-
ism’s ability to grow under specific conditions. For
example, given a specific set of nutrient conditions, flux
balance analysis (FBA) of metabolic networks can accu-
rately predict microbial cellular growth rates
[13,15-17,23]. In a recent work, Raghunathan et al. [24]
used an approximate representation of in-host nutrient
availability inferred from the literature to simulate the
in-host metabolism of Salmonella typhimurium.M o r e -
over, metabolic network analyses can then be used to
identify organism-specific essential genes by predicting
the attenuation of microbial growth of specific deletion
mutants [13-17,19]. Metabolic genes that are essential
for pathogen growth but are not present in humans
constitute actual and potential drug targets [6,19].
Using the sequenced genome of M. tuberculosis [25]
together with literature data on known metabolic reac-
tions, extensive metabolic network reconstructions have
been carried out for this organism [15,16]. Analyses of
these networks based on FBA revealed that they contain
sufficient information to predict growth rates and iden-
tify genes that are essential for the growth of M. tuber-
culosis in select media [15,16]. We have also used the in
vitro network to model the drug-induced growth inhibi-
tion of M. tuberculosis when grown on defined media
[ 2 6 ] .H o w e v e r ,s i m u l a t i o no fM. tuberculosis growth in
an in vivo host environment based on an in vitro model
is hindered by a lack of understanding of the pathogen’s
metabolism in the often poorly defined in vivo environ-
ment [7,27]. To experimentally explore the cellular
activities of this pathogen in hosts, several methodolo-
gies have been developed. High-throughput gene expres-
sion experiments have been performed for
M. tuberculosis in murine macrophage cells [28] and
cells from mouse lung tissue [29]. Gene expression data
have been interpreted, using the metabolic network of
M. tuberculosis, to predict the production of mycolic
acid [30]. Gene deletion experiments on M. tuberculosis,
including individual [31-33] and high-throughput gene
deletion studies [34], have identified genes that are
essential in the murine host environment. In particular,
Sassetti et al. developed the transposon site hybridiza-
tion (TraSH) technique to identify genes required for
M. tuberculosis growth in an in vitro medium [35] and
genes specifically required for survival during in vivo
infection [34]. This assay tested 2,979 genes, including a
large fraction of genes known to be involved in
metabolism.
For modeling, gene essentiality data per se are typically
used to verify that a genome-scale metabolic network
reconstruction is accurate; however, these data can also
be used in the refinement process itself, either for speci-
fic pathways [36] or for the entire network [37-39], in
which gene annotations, reactions, and biomass objec-
tive functions are adjusted based on gene essentiality
data [37-39]. Moving away from these more or less ad
hoc corrections, Kumar and Maranas [39] explored an
automated and systematic way of reconciling in silico/in
vivo growth predictions in large-scale metabolic net-
works. Here, we build on ande x t e n dt h e s er e f i n e m e n t
methodologies to develop an enhanced set of systematic
procedures to modify the in vitro metabolic network
model of M. tuberculosis iNJ661 [15] and develop a net-
work model that is more consistent with in vivo meta-
bolism during the initial eight-week post-infection
period. Importantly, the resultant network modifications
provide indirect insights into the nutrient availability
and metabolic states of M. tuberculosis in the mouse
host environment. Furthermore, we used the newly
developed in vivo network to predict the growth of
double-deletion mutants to identify drug targets that are
either specific for the host environment or common to
both in vivo and in vitro conditions.
Methods
To develop a M. tuberculosis metabolic network model
commensurate with an in vivo cellular environment, we
modified an existing network in two separate steps.
First, we corrected an existing in vitro network model to
account for missing or inconsistent chemical reactions
and metabolites, and then, through a systematic set of
procedures, we modified this network to be compatible
with gene essentiality data generated under in vivo
conditions.
Modified in vitro network iNJ661m
We used the iNJ661 metabolic network model of M.
tuberculosis H37Rv [15], which reproduces in vitro
experimentally observed growth rates in different media,
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network, iNJ661 m, models cellular growth in Middleb-
rook 7H9 medium supplemented with glucose and gly-
cerol. We then used the GSMN-TB metabolic network
of M. tuberculosis [16] to supplement reactions and
metabolites in the modified network. We corrected the
network with respect to biotin synthesis, fumarate and
succinate synthesis, added the methylcitrate cycle, added
a redundant annotation for the b-hydroxybutyryl-CoA
dehydrogenase enzyme, and made minor changes to the
biomass function (see Supplemental Section S1 in Addi-
tional file 1 for details). These modifications did not
change the previously reported growth rates [15]. The
resulting iNJ661m network model contained 663 genes,
838 metabolites, and 1,049 reactions. The developed
network is provided in the Additional files in both Sys-
tems Biology Markup Language (Additional file 2) and
Excel formats (Additional file 3).
Prediction of essentiality of single genes and gene pairs
We used FBA of the metabolic networks to predict the
essentiality of single genes. Using linear programming,
FBA can maximize the cellular growth rate subject to
the steady-state mass balance of all the intracellular
metabolites and the stoichiometric constraints defined
by the reactions [40-42]. For the metabolic network
models, we performed FBA to calculate the growth rate
of wild-type M. tuberculosis and the growth rates of all
single-gene deletion mutants. If the ratio of a single-
gene deletion mutant growth rate to wild-type growth
rate was less than a threshold (0.2), we labeled the gene
as essential; otherwise, it was deemed as non-essential.
Since the growth rate ratios obtained from FBA were
either <10
-4 or >0.2, the chosen threshold value of 0.2
differentiated growth rate ratios close to zero from
those significantly higher than zero.
We compared the predicted gene essentiality with
experimentally determined in vivo essentiality in mice
[34,36] and defined four categories of predictions: true
positives (TP), denoting genes that were predicted to be
essential and were also essential in the experiment; true
negatives (TN), denoting genes that were both predicted
and experimentally determined to be non-essential; false
negatives (FN), representing genes that were predicted
to be non-essential but were experimentally essential;
and false positives (FP), denoting genes that were pre-
dicted to be essential but were experimentally non-
essential.
We predicted the synthetic essentiality of gene pairs in
M. tuberculosis by calculating the growth rates of all
possible double-gene deletion mutants in the metabolic
network models. Two genes were classified as syntheti-
cally essential if each single individual gene deletion did
not affect the growth of the organism, whereas the
double-gene deletion impaired growth. Similar to the
predictions for single-gene deletion mutants, we classi-
fied a deleted gene pair as synthetically essential if the
ratio of the growth rate of the double-gene deletion
mutant to that of the wild-type bacterium was smaller
than the threshold (0.2) and the ratios for the two sin-
gle-gene deletions were greater than the threshold.
Modifications used to construct the in vivo network
iNJ661v
We developed a systematic set of procedures to opti-
mally modify an existing metabolic network based on
discrepancies in gene essentiality between computa-
tional predictions and experimental data. We applied
the procedures to modify the original in vitro network,
iNJ661 m, to optimally reproduce gene essentiality
under an in vivo condition and create an in vivo net-
work, iNJ661v. Figure 1 shows an overview of the five
main steps of the procedure set, each of which is dis-
cussed in detail below. In Step I,w ec o m p a r e dt h e
gene essentiality of iNJ661m with experimental in vivo
data and identified the set of FP and FN predictions.
In Step II, for each incorrect prediction, we attempted
to obtain a set of possible modifications to correct the
predictions, commensurate with a minimum number
of adjustments to iNJ661 m. In Step III, we combined
all obtained modifications for each of the incorrect
predictions and screened the sets of combined modifi-
cations to identify rational and consistent sets of meta-
bolic modifications. In Step IV,w ea n a l y z e dt h e
availability and blockage of nutrient uptakes based on
the original iNJ661m network and attempted to use
small, chemically uncomplicated molecules as nutrient
sources and to reduce the number of uptakes. Finally,
in Step V, we reviewed the relevant literature to verify
the biochemical and biological veracity of the intro-
duced modifications. This set of procedure generated a
number of different resultant networks, each represent-
ing a “minimal” adjustment that can optimally repro-
duce the given gene essentiality data. Because it is
desirable to create a single unique network representa-
tion suitable for modeling and computational analysis,
and because we do not have enough information to a
priori discriminate against any particular network
representation, we combined all networks as long as
the combination did not generate any new incorrect
predictions. Thus, the resultant network description
iNJ661v corresponds to an unbiased assembly of mini-
mal adjustments compatible with the experimental
data.
Step I: Collation of the FP and FN predictions
The wrongly predicted FP and FN genes were collated
as identified from the gene essentiality predictions
described above.
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Figure 2 shows the two types of network modifications
we used to remove FP predictions. For each FP predic-
tion, we first attempted to correct it by removing meta-
bolites from the biomass objective function of the
original iNJ661m network. In the original iNJ661 net-
work, 16 vitamins and cofactors were included as part
of the biomass based on in vitro gene essentiality data
but without any experimental verification [15], suggest-
ing that these metabolites might not be part of the bio-
mass when M. tuberculosis grows in a different
nutritional environment. Therefore, we systematically
investigated the removal of one or more of these 16
metabolites. Initially, we removed one metabolite at a
time from the biomass objective function and recorded
the removals that corrected the FP prediction and
caused no original TP prediction to become FN. If the
single-metabolite removal did not correct the FP predic-
tion, we expanded the removal to include all pairwise
removals, and so on, until exhaustion or until the pre-
diction was corrected. The second set of attempts to
correct FP predictions introduced new nutrient uptakes
Figure 1 Main steps for the development of the iNJ661v network.I nStep I, we compared the gene essentiality of iNJ661m with
experimental in vivo data and identified the set of false positive (FP) and false negative (FN) predictions. In Step II, for each incorrect prediction,
we attempted to obtain a set of possible modifications. In Step III, we combined all the suggested modifications for each different incorrect
prediction and screened the network realizations to obtain adequate and consistent metabolic modifications. In Step IV, we analyzed the
availability and blockage of nutrient uptakes. In Step V, we reviewed the relevant literature to verify the biochemical and biological veracity of
the introduced modifications. TN, true negative; TP, true positive.
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procedure is based on the optimization model that
Kumar and Maranas [39] developed to resolve FP incon-
sistencies in the E. coli metabolic network by adding a
minimum number of reactions from a pool of reactions
collected from multi-organism databases (MetaCyc [43]
and KEGG [44]). We used the same optimization
model, where the pool of potentially added reactions
consisted of 1) all uptake reactions blocked in the origi-
nal iNJ661m network and 2) all irreversible reactions in
iNJ661m with their directions reversed. We used this
model to obtain the modification(s) that changed the
minimum number of irreversible reactions, and accepted
the modification(s) if the changed irreversible reaction(s)
was (were) reported as thermodynamically reversible in
either the metabolic network of E.coli [13] or that of
Bacillus subtilis [45]. These two networks include ther-
modynamic reversibility data. All attempts to correct for
the FP predictions by removal of metabolites from the
biomass objective function and addition of reactions
were performed in parallel. Each modification used the
same iNJ661m network as the starting point. The set of
identified modifications was then analyzed together in
Step III: analysis of combined modifications.
Step II: FN correction procedure
Figure 3 shows the more complex procedures we used
to correct the FN predictions. We initially listed all
reactions catalyzed by the product of FN genes. For
each reaction, we first examined whether the reaction
required the presence of both a FN gene and one or
more TN genes. If this were the case, no correction of
the FN prediction was possible because a correction
would have caused the predicted TN genes to become
FP. If this were not the case, we attempted to correct
the FN prediction by blocking the ability of isozyme(s)
of the FN gene product to catalyze the reaction. Next,
we examined whether the reaction was in a dead-end
pathway, i.e., a pathway containing metabolites that
cannot be produced, metabolites that cannot be
c o n s u m e d ,o rb o t h .I fam e t a b o l i t ec o u l dn o tb ep r o -
duced, and the uptake reaction for this metabolite
existed but was blocked in iNJ66 m, we restored the
uptake. If a metabolite could not be consumed, we
added this metabolite to the biomass objective function
with a coefficient of 10
-6 mmol/gDW, that is, mmol per
gram dry weight of M. tuberculosis. This coefficient was
used in the biomass objective function of the original
iNJ661 network to include metabolites for which quanti-
tative biomass composition data were not available [15].
Finally, if the above analysis of the dead-end pathway
did not correct the FN prediction or the reaction was
not in a dead-end pathway, we attempted to correct the
FN prediction by suppressing one or more reactions in
iNJ661 m. For this procedure, we used the optimization
Figure 2 Procedure to correct false positive (FP) gene essentiality predictions. For each predicted FP gene, we attempted to correct the
prediction by (I) removing metabolites from the biomass objective function and (II) introducing new nutrient uptakes and/or changing
irreversible reactions to reversible (using the optimization model developed by Kumar and Maranas [39]). When a modification was successful, as
determined by the criteria shown in Figure 4, we recorded and collected it in a set of possible modifications. TN, true negative; RXN, reaction;
Y, yes.
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ving FN inconsistencies and selected the modification(s)
that suppressed the minimum number of reactions.
Note that, to correct for FP and FN predictions in the
Step II procedures, we needed to assess whether a modi-
fication was adequate. Figure 4 shows the criteria we
used to determine this. A modification was adequate if,
after applying the modification to iNJ661 m, the follow-
ing three criteria were satisfied: 1) the calculated wild-
type growth rate was greater than the minimal rate
(taken to be 0.027 h
-1, according to the growth rate of
M. tuberculosis in mouse macrophages [32]), 2)t h eF P
or FN prediction was corrected, and 3)n oT P ( T N )p r e -
diction became FN(FP).
Step III: Analysis of combined modifications
After the completion of Step II,t h e r em i g h tb em o r e
than one modification used to correct for each of the FP
or FN predictions, and we needed to analyze the conse-
quences of combining these modifications into a single
network description. Figure 5 summarizes these ana-
lyses. We first listed all possible network realizations,
where each realization represented a set of combined
modifications. Thus, if there were two possible modifica-
tions that correct for the prediction of gene A,t h r e e
possible modifications that correct for the prediction of
gene B, etc., then there would be 2*3*... possible network
realizations, where each realization includes one modifi-
cation for each incorrect prediction. Next, for each
Figure 3 Procedure to correct false negative (FN) gene essentiality predictions. For each reaction associated with a FN gene, we first
examined whether the reaction required the presence of both the FN gene and one or more TN genes. If this was not the case, we attempted
to correct the FN prediction by blocking the functions of isozyme(s). Next, we examined whether the reaction was in a dead-end pathway, i.e., a
pathway containing metabolites that cannot be produced, metabolites that cannot be consumed, or both. If this was the case, we added (I)
metabolite uptakes or (II) metabolites to the biomass objective function. The last attempt was to correct the FN prediction by suppressing one
or more reactions (using the optimization model developed by Kumar and Maranas [39]). When a modification was successful, as determined by
the criteria shown in Figure 4, we recorded and collected it in a set of possible modifications. RXN, reaction; TN, true negative; TP, true positive;
Y, yes; N, no.
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contained contradictory modifications, e.g., one modifi-
cation in the network blocked a reaction flux, whereas
another modification allowed for the same reaction flux,
or one modification added a metabolite to the biomass
objective function, whereas another modification
removed it. If contradictory modifications were not
detected, then we applied the modifications to iNJ661m
and verified that 1) the wild-type growth rate (calculated
from FBA) was greater than the minimal rate, 2) incor-
rect predictions were corrected, and 3)c o r r e c tp r e d i c -
tions (TP or TN) were still correct. If true, we recorded
the network as plausible. Finally, from all plausible net-
works, we selected the ones that were associated with
the smallest number of adjustments (i.e., the smallest
number of irreversible reaction changes and reaction
suppressions).
Step IV: Nutrient uptake analysis
In Step II, we allowed for the addition and removal of a
fixed set of nutrient uptakes, leaving other nutrient
uptakes (blocked or unblocked) of iNJ661m unexamined.
Here, we re-examined these uptakes in light of the
altered nutritional environment under in vivo conditions.
The harsh nutritional environment that M. tuberculosis
confronts when the bacterium infects a mouse suggests
that nutrient uptake is limited and restricted to generally
available small molecules as possible metabolite sources.
Thus, we implemented a nutrient uptake-based analysis
procedure to eliminate uptakes of complex nutrients as
much as possible while minimizing the number of addi-
tional small-molecule uptakes and maintaining the com-
patibility with the in vivo gene essentiality data. The
primary location of M. tuberculosis in a recently infected
animal is the phagosomal compartments of macrophages.
Figure 4 Criteria to judge whether a modification for an incorrect prediction is adequate. A modification was deemed to be adequate if,
after applying the modification to iNJ661 m, the following criteria were met: 1) the calculated wild-type growth rate was greater than the
minimal rate (taken to be 0.027 h
-1, according the growth rate of M. tuberculosis in mouse macrophages [32]), 2) the false positive (FP) or false
negative (FN) prediction was corrected, and 3) no true positive (TP) or true negative (TN) prediction became FN or FP, respectively. Y, yes; N, no.
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down into smaller ones. For example, macrophages
decompose proteins into amino acids [46], which in turn
are decomposed into smaller molecules, such as nitrite
and nitrate [47]. Therefore, we assumed that the in vivo
nutrient environment did not contain a significant abun-
dance of all large molecules, such as amino acids, but
rather was primarily composed of small molecules, such
as nitrite, nitrate, ammonia, phosphate, and so on. How-
ever, as some large molecules may not be broken down,
we still kept the uptakes for these molecules in two cases:
1) if their uptakes was added during the correction of a
false gene essentiality prediction (for example, fatty
acids); and 2) if deletions of these uptakes caused a
growth rate lower than the defined threshold or gener-
ated new false gene essentiality predictions.
Figure 5 Procedures to analyze combined modifications for different incorrect predictions. Each network realization included one
modification for every incorrect prediction. A plausible network realization satisfied the following criteria: 1) the network contained no
contradictory modification, and, after the combined modifications to iNJ661m were applied, 2) the wild-type growth rate (calculated from flux
balance analysis) was greater than the minimal rate (taken to be 0.027 h
-1 according the growth rate of M. tuberculosis in mouse macrophages
[32]), 3) incorrect predictions were corrected, and 4) existing correct predictions before the applied modification were still correct. Finally, from all
plausible network realizations, we selected the networks that were associated with minimum adjustment. TN, true negative; TP, true positive; FN,
false negative; TN, true negative; Y, yes; N, no.
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of available small-molecular-weight metabolites that
1) contained the necessary atomic elements found
among the biomass molecules, i.e., carbon, nitrogen,
oxygen, phosphorus, sulphur, iron, potassium, and
sodium; 2) had a recorded uptake reaction in iNJ661m;
and 3) contained a minimum number of other ele-
ments. Based on the elements, these small-molecule
metabolites were then grouped accordingly: carbon
monoxide (CO) and carbon dioxide (CO2) for carbon;
ammonium (NH4
+), nitrite (NO2
-), and nitrate (NO3
-)
for nitrogen; O2 for oxygen; phosphate (HPO4
2-)f o r
phosphorus; sulphate (SO4
2-) for sulphur; ferrous (Fe
2
+)a n df e r r i c( F e
3+) ions for iron; K
+ for potassium; and
Na
+ for sodium. Note that nitric oxide (NO) is a small
nitrogen-containing molecule that was not included in
the analysis as it is generated as part of the host
defense system rather than acting as a nitrogen source
[48]. Commensurately, we also blocked the reaction
catalyzed by cytochrome c oxidase because experiments
have suggested that NO prevents the function of this
enzyme [48]. Note that this is the only literature source
we used before proceeding to the literature analysis
and verification in Step V.
For each network realization from Step III,w e
divided all uptake reactions into the following two sets:
1)a“minimal” uptake set comprising the uptakes of
H2Oa n dH
+, all uptakes added in Step II,a n dt h e
uptakes of the small molecules defined above (minimal
set); and 2)a n“extended” uptake set comprising all
other defined uptake reactions in iNJ661m (extended
set). Initially, we allowed uptake reactions from the
minimal set and blocked all reactions from the
extended set. As expected, this resulted in a non-biolo-
gical network displaying an overall growth rate of zero.
We then used the minimization procedure adopted
from Kumar and Maranas [39] to determine the smal-
lest set of uptake reactions in the extended set that
restored a minimal growth rate and introduced no new
FP or FN predictions.
Next, we fixed this set of uptake reactions and investi-
gated which small-molecule uptake reactions from the
minimal set were dispensable, i.e., we tried to find a
minimal set of uptakes that was still compatible with
growth. To do this, we allowed metabolite uptakes for
all members of the small-molecule set and investigated
removal of specific uptakes based on each element
group as defined above. We did this by systematically
removing, for each element group, all combinations of
small-molecule uptakes and recording which combina-
tions resulted in a wild-type growth rate that was
greater than the minimal rate and where each of the TP
and TN predictions were preserved. For example, for
the carbon group, we investigated the possibilities of
1) removing both the CO and CO2 uptakes, 2) removing
only the CO uptake, and 3)r e m o v i n go n l yt h eC O 2
uptake. When investigating the next element group, all
other small-molecule metabolite uptakes were restored.
Finally, we selected the minimal number of small-mole-
cule uptakes for each element that was compatible with
maintaining wild-type growth and preserving the true
gene essentiality predictions.
All the computational correction procedures above
(Steps II-IV) were fully automated and attempted to cap-
ture all feasible minimal modifications to the network
that optimized compatibility with the gene essentiality
data. Supplemental Section S2 in Additional file 1 shows
a more detailed description of these procedures. Since
all feasible corrections for each false prediction were
collected, it was possible to obtain more than one resul-
tant network. To generate the single in vivo network
iNJ661v, we included all feasible modifications, as long
as no new incorrect predictions or contradictory nutri-
ent uptakes were generated.
Step V: Literature analysis and verification
We reviewed the available literature on M. tuberculosis
to examine the biological rationale of our modifications.
The presence of supporting data from the literature sug-
gested that our systematic procedures could provide
insights into in vivo metabolism. The absence of litera-
ture citations for specific modifications indicated the
need for possible future experimental work to link meta-
bolism and gene essentiality data.
Statistic analyses of metabolic networks
We used statistical methods to compare the ability of
the three metabolic network models (iNJ661, iNJ661 m,
and iNJ661v) to predict experimental in vivo gene essen-
tiality [34]. For each of the three networks, we obtained
the total numbers of TP, TN, FN, and FP genes and
compared the corresponding sensitivity and specificity.
We also calculated Matthews correlation coefficients
(MCCs) to evaluate the ability of the networks to pre-
dict and classify gene essentiality [49]. The MCC mea-
sures the correlation between observed and predicted
binary classifications and ranges in values from +1 to -1,
with +1 indicating a perfect prediction, 0 indicating a
random prediction, and -1 indicating an inverse predic-
tion. The calculated sensitivity, specificity, and MCCs
depend on the value chosen for the growth rate ratio
threshold to determine gene essentiality. To gauge the
overall performance of the designed metabolic network
model, we calculated receiver operating characteristic
(ROC) curves for the studied networks. The ROC curve
provides sensitivity as a function of 1 minus specificity
across all possible threshol d s[ 5 0 ] ,a n d ,b ye s t i m a t i n g
the 95% confidence interval of the area under the ROC
curve (AUC), we can quantitatively assess and compare
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model [51].
Results
Development of the modified in vivo network iNJ661v
Sassetti et al. [35] experimentally identified the genes
essential for M. tuberculosis growth within an in vitro
medium. We used the data from this in vitro experi-
ment to verify the ability of iNJ661 and iNJ661m to pre-
dict in vitro gene essentiality. In addition, Sassetti and
Rubin [34] adapted the TraSH technique to test for
genes specifically required for the survival of M. tuber-
culosis during infection of the pathogen in mice [34].
Although this technique cannot positively identify in
vivo essential genes whose deletion mutants are highly
attenuated within the in vitro medium, the differentially
identified set provides unique insights into the changed
metabolic state of the pathogen [34]. In addition, Mur-
phy et al. [36] showed that the otsB2 gene is essential
for M. tuberculosis under in vivo conditions. We used
the data from these two in vivo experiments [34,36] as
the basis for our manipulations of metabolic reactions
and metabolites to obtain a metabolic network (iNJ661v)
that was compatible with pathogen growth under in vivo
conditions.
Table 1 shows the predicted gene essentiality data
based on FBA of iNJ661 [15], iNJ661 m, and GSMN-TB
[16] as well as a comparison of the results with in vitro
experimental datasets [35]. To verify our ability to cor-
rectly analyze the metabolic networks, we first repeated
the original work of Jamshidi and Palsson [15] using the
criterion that any gene whose deletion mutant had a
growth rate less than that of the wild type, i.e., the
mutant growth rate ratio was <1, was considered to be
essential for growth. Our analysis of iNJ661 yielded 153
TP genes and 84 FN genes using a growth rate ratio
threshold of 1.0. Due to minor numerical differences in
cutoffs and constraint values in the FBA, these numbers
were slightly different from the published results (154
TP and 83 FN) [15]. When the growth rate ratio thresh-
old was lowered to 0.2, the sensitivity decreased from
0.65 to 0.57, whereas the specificity increased from 0.77
to 0.81. In addition, iNJ661 gave MCC values ranging
from 0.39 to 0.42 depending on the specific threshold.
We also performed the same calculations for iNJ661m
and GSMN-TB. We obtained very similar results for
iNJ661 m, suggesting that iNJ661m had the same ability
to predict in vitro gene essentiality. The agreement
between the GSMN-TB-predicted essentiality and the in
vitro experimental data was slightly better than that for
the other two networks, with MCC values for GSMN-
TB ranging from 0.49-0.52.
In contrast to the in vitro results, the in vivo-predicted
essentiality of iNJ661, iNJ661 m, and GSMN-TB was
less satisfactory. Using the designated in vivo biomass
composition formulation in the GSMN-TB network
(indicated as GSMN-TBv) provided a slightly larger sen-
sitivity in the essentiality prediction, but the improve-
ment was only modest. The sensitivity for the predicted
essentiality of these networks ranged from 0.23 to 0.44
depending on the threshold used. MCC values also
decreased to 0.03-0.11 when we used these networks to
predict in vivo essentiality. The relatively poor match
between these predictions and the in vivo experimental
data suggests that iNJ661, iNJ661 m, and GSMN-TB(v)
are inappropriate to describe the metabolic activity of
M. tuberculosis under in vivo conditions.
Therefore, we attempted to obtain the new network by
modifying an existing metabolic network of M. tubercu-
losis. Among the two available networks [15,16], we
selected iNJ661 as the starting point because it is based
on the H37Rv strain of M. tuberculosis used in the in
vivo gene essentiality experiments [34,36]. In contrast,
the GSMN-TB construct is meant to be a general, non-
strain specific model of M. tuberculosis metabolism.
iNJ661 also successfully predicts the growth rate of M.
tuberculosis H37Rv in two different media: Youmans
and the “chemically defined rich culture media,” while
the growth rates predicted from GSMN-TB are only
compared with experimental data for M. bovis BCG.
S i n c et h ek e ya i mo fo u rw o r k is to mimic as faithfully
as possible the H37Rv strain, we choose not to use the
GSMN-TB network as our starting point, although we
used reactions relevant to the H37Rv strain from the
GSMN-TB network to augment our construction.
We used iNJ661 m, the slightly improved version of
iNJ661, as a starting point and performed the systematic
p r o c e d u r e ss h o w ni nF i g u r e 1 to develop a modified
metabolic network (iNJ661v) to better describe the in
vivo metabolic activity of M. tuberculosis. Table 1 shows
that the comparison between the in vivo experimental
essentiality and the predicted essentiality of iNJ661m at
the end of Step I yielded 76 FP and 25 FN predictions
with a threshold of ≤0.2. All 25 FN and 76 FP genes
were taken as input to Step II. The automated FP and
FN correction procedures shown in Figures 2 and 3
were able to correct 24 of the 76 FP predictions and 18
of the 25 FN predictions, respectively. Additional file 1,
Table S1 shows all the possible minimal corrective mod-
ifications for each of 42 (24 + 18) predictions.
Since there were multiple ways in which we could
combine the different modifications, it became necessary
to try to reduce the number of possible network realiza-
tions, as outlined in Step III. As shown in Additional file
1, Table S1, we had 35 groups of genes whose products
each catalyze the same reaction and whose predictions
can be corrected by creating the necessary conditions
that makes the reaction essential for FN predictions or
Fang et al. BMC Systems Biology 2010, 4:160
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Page 10 of 24non-essential for FP predictions. For 30 groups there is
only one possible modification, for two groups there are
five possible modifications each, and for three groups
there are two possible modifications each, resulting in a
total of 1
30 ×5
2 ×2
3 = 200 possible network realiza-
tions. Next, we examined each one of these using the
criteria shown in Figure 5 to weed out inadequate net-
works. Table 2 shows the modifications that survived
this analysis, resulting in 31 groups with only one possi-
ble modification and four groups with two possible
modifications each, resulting in a total of 1
31 ×2
4 =1 6
plausible network realizations.
In Step IV, we re-examined the assigned nutrient
uptakes in the networks as outlined in the Methods Sec-
tion. This analysis was performed for each of the 16 net-
work realizations from Step III, each yielding the same
set of uptakes. Table 3 shows that this set of uptakes
comprises the default uptakes of H2Oa n dH
+ (these two
metabolites are always considered to be available), a
minimum number of uptakes of small molecules, uptakes
added based on the Step II analysis, and glycerol. We
further decreased the upper limit of glycerol input to
0.06 mmol·h
-1·gram dry weight
-1 until lower values of the
glycerol input caused the fum gene to be incorrectly pre-
dicted as essential under in vivo conditions. Each of the
resultant 16 networks contained the same set of uptakes
and yielded the same number of correct predictions.
Since we had no prior information to discriminate
among these networks, we applied all modifications to
iNJ661 m. Because this combination did not generate any
new incorrect gene essentiality predictions, we designated
this network as the “optimal” unbiased construction of
the in vivo network iNJ661v.
The iNJ661v network contained 663 genes, 838 meta-
bolites, and 1,049 reactions and is provided in the Addi-
tional files in both Systems Biology Markup Language
(Additional file 4) and Excel formats (Additional file 5).
Based on this network, we re-calculated gene essentiality
through FBA and compared the predictions with the
experimental essentiality data in mice [34,36]. Table 1
shows the results from the comparison of the in vivo
gene essentiality predictions of iNJ661v with those
Table 1 Comparison of predicted and experimental gene essentiality using different networks and different growth
conditions
Network Experiment
Condition
Threshold Number of Gene Essentiality Predictions Sensitivity Specificity Matthews Correlation
Coefficient
TP FN FP TN
iNJ661 In vitro <1.0 153 84 71 236 0.65 0.77 0.42
iNJ661m In vitro <1.0 153 85 71 237 0.64 0.77 0.42
GSMN-TB In vitro <1.0 156 85 58 294 0.65 0.84 0.49
GSMN-TBv In vitro <1.0 160 81 75 277 0.66 0.79 0.45
iNJ661v In vitro <1.0 140 98 80 228 0.59 0.74 0.33
iNJ661 In vitro ≤0.2 135 102 59 248 0.57 0.81 0.39
iNJ661m In vitro ≤0.2 135 103 59 249 0.57 0.81 0.39
GSMN-TB In vitro ≤0.2 152 89 47 305 0.63 0.87 0.52
GSMN-TBv In vitro ≤0.2 156 85 65 287 0.65 0.82 0.47
iNJ661v In vitro ≤0.2 123 115 63 245 0.52 0.80 0.33
iNJ661 In vivo <1.0 16 20 97 242 0.44 0.71 0.10
iNJ661m In vivo <1.0 16 20 94 246 0.44 0.72 0.11
GSMN-TB In vivo <1.0 10 34 76 317 0.23 0.81 0.03
GSMN-TBv In vivo <1.0 16 28 93 300 0.36 0.76 0.09
iNJ661v In vivo <1.0 31 5 77 263 0.86 0.77 0.41
iNJ661 In vivo ≤0.2 11 25 76 263 0.31 0.78 0.06
iNJ661m In vivo ≤0.2 11 25 76 264 0.31 0.78 0.06
GSMN-TB In vivo ≤0.2 10 34 65 328 0.23 0.83 0.05
GSMN-TBv In vivo ≤0.2 16 28 83 310 0.36 0.79 0.11
iNJ661v In vivo ≤0.2 29 7 52 288 0.81 0.85 0.47
A true positive (TP) prediction refers to a gene correctly predicted to be essential, whereas a false negative (FN) prediction refers to a gene incorrectly predicted
to be non-essential. A false positive (FP) prediction refers to a gene incorrectly predicted to be essential, whereas a true negative (TN) prediction refers to a gene
correctly predicted to be non-essential. Sensitivity = TP/(TP + FN). Specificity = TN/(TN + FP). Matthews correlation coefficient = (TP × TN - FP × FN)/[(TP + FP)(TP
+ FN)(TN + FP)(TN + FN)]
1/2. GSMN-TBv indicates the GSMN-TB network with its in vivo biomass objective function.
Fang et al. BMC Systems Biology 2010, 4:160
http://www.biomedcentral.com/1752-0509/4/160
Page 11 of 24Table 2 Summary of modifications to correct gene essentiality predictions after Step III
Gene
Group
No.
Gene
No.
Gene
Locus
Gene
Name
FP/
FN
Pathway Function/Reaction Modification to Correct the False Gene
Essentiality Prediction
Supporting
Literature
(References)
11 Rv1099c Rv1099c FN Glycolysis/
gluconeogenesis
Convert fructose-1,6-
bisphosphate into fructose-
6-phosphate
(1) Blocked the uptake of glucose from
environment
[8,28,32,52-57]
22 Rv2702 ppgK FN Glycolysis/
gluconeogenesis
Conversion between
glucose-6-phosphate and
glucose
(1) Blocked the conversion from maltose
to glucose and blocked the uptake of
glucose
(2) Blocked the conversion between
maltose and trehalose and blocked the
uptake of glucose
[8,28,32,52-57]
33
4
5
Rv1350
Rv1483
Rv2947c
fabG2
inhA
pks15
FP
FP
FP
Fatty acid
metabolism
Synthesis of fatty acids (1) Allowed the uptakes of the following
fatty acids: hexadecanoate, octadecanoate,
octanoate, dodecanoate, arachidic acid,
and hexacosanoate
[8,28,32,52-57]
46 Rv2503c scoB FP Fatty acid
metabolism
Functions as 3-oxoacid CoA-
transferase
(1) Let the reaction catalyzed by acetyl-
CoA:acetoacetyl-CoA transferase be
reversible
57 Rv3229c desA3 FN Fatty acid
metabolism
Palmitoyl-CoA desaturation (1) Blocked the synthesis of
hexadecenoate
[8,28,32,52-57]
68 Rv1185c fadD21 FN Fatty acid
metabolism
Synthesis of fatty acid-CoA (1) Blocked the ability of fadD9 (Rv2590),
fadD24 (Rv1529), and fadD23 (Rv3826)t o
catalyze the synthesis of fatty acid-CoA
79 Rv0098 Rv0098 FN Fatty acid
metabolism
Mycolic acid synthesis (1) Blocked the ability of fabG1 (Rv1483)t o
catalyze the same reaction
81 0 Rv2483c plsC FN Fatty acid
metabolism
Synthesis of 1,2-diacyl-sn-
glycerol 3-phosphate (a
phospholipid)
(1) Blocked the ability of Rv2182c to
catalyze the same reaction
91 1 Rv1416 ribH FP Vitamin and
cofactor
metabolism
Synthesis of riboflavin (1) Removed riboflavin and flavin
mononucleotide (FMN) from the biomass
objective function
10 12 Rv1412 ribC FP Vitamin and
cofactor
metabolism
Synthesis of riboflavin (1) Removed riboflavin and FMN from the
biomass objective function
11 13 Rv2671 ribD FP Vitamin and
cofactor
metabolism
Synthesis of riboflavin
precursor
(1) Removed riboflavin and FMN from the
biomass objective function
12 14 Rv2786c ribF FP Vitamin and
cofactor
metabolism
Synthesis of FMN from
riboflavin
(1) Removed FMN from the biomass
objective function
13 15 Rv2421c Rv2421c FP Vitamin and
cofactor
metabolism
Synthesis of deamino-NAD
+ (1) Removed nicotinamide adenine
dinucleotide (NAD) and nicotinamide
adenine dinucleotide phosphate (NADP)
from the biomass objective function
14 16 Rv1596 nadC FP Vitamin and
cofactor
metabolism
Functions as nicotinate-
nucleotide diphosphorylase
(1) Removed NAD and NADP from the
biomass objective function
15 17 Rv3215 entC FP Vitamin and
cofactor
metabolism
Synthesis of isochorismate (1) Removed menaquinol 8 from the
biomass objective fucntion
16 18 Rv1568 bioA FN Vitamin and
cofactor
metabolism
Synthesis of a precursor of
biotin
(1) Added biotinyl-5’-AMP to the biomass
objective function
17 19 Rv1569 bioF FN Vitamin and
cofactor
metabolism
Synthesis of a precursor of
biotin
(1) Added biotinyl-5’-AMP to the biomass
objective function and blocked the ability
of bioF2 (Rv0032) to catalyze the same
reaction
18 20 Rv1589 bioB FN Vitamin and
cofactor
metabolism
Synthesis of biotin (1) Added biotinyl-5’-AMP to the biomass
objective function
Fang et al. BMC Systems Biology 2010, 4:160
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19 21 Rv2211c gcvT FN Vitamin and
cofactor
metabolism
Conversion between 5-
formyltetrahydrofolate and
5,10-
methenyltetrahydrofolate
(1) Added the metabolite 5-
formyltetrahydrofolate to the biomass
objective function
20 22 Rv3001c ilvC FP Amino acid
metabolism
Synthesis of 2,3-dihydroxy-3-
methylbutanoate and 2,3-
dihydroxy-3-
methylpentanoate
(1) Allowed the uptakes of isoleucine and
valine
[61]
21 23 Rv3002c ilvN FP Amino acid
metabolism
Synthesis of acetolactate (1) Allowed the uptake of valine [61]
22 24
25
26
27
Rv2220c
Rv1878
Rv2222c
Rv2860c
glnA1
glnA3
glnA2
glnA4
FP
FP
FP
FP
Amino acid
metabolism
Synthesis of glutamine (1) Let the reaction of glutamate synthesis
from glutamine to be reversible
(2) Let the conversion to CTP and
glutamate from UTP and glutamine be
reversible
23 28 Rv3754 tyrA FP Amino acid
metabolism
Functions as prephenate
dehydrogenase
(1) Allowed the uptake of tyrosine
24 29 Rv3042c serB2 FN Amino acid
metabolism
Remove a phosphate group
from phosphoserine to
produce serine
(1) Blocked the ability of serB (Rv0505c)t o
catalyze the same reaction
25 30 Rv2231c cobC FN Amino acid
metabolism
Convert glutamate into
histidinol-phosphate
(1) Blocked the ability of hisC2 (Rv3772)
and hisC (Rv1600) to catalyze the
conversion
26 31 Rv2945c lppX FN Transport Transport phthiocerol
dimycocerosate A and
phenol phthiocerol
dimycocerosate out of the
cell
(1) Added extracellular phthiocerol
dimycocerosate A to the biomass
objective function
(2) Added extracellular phenol phthiocerol
dimycocerosate to the biomass objective
function
[62]
27 32
33
34
Rv1236
Rv1237
Rv1238
sugA
sugB
sugC
FN Transport Transport of glucose,
maltoheptaose, maltose,
ribose, trehalose, and xylose
into cell
(1) Allowed xylose uptake and added
xylose to the biomass objective function
28 35 Rv3236c kefB FN Transport Transport of K
+ and Na
+
into the cell
(1) Blocked the function of potassium ABC
transporter
(2) Blocked the function of the Na
+
antiporter
29 36 Rv1699 pyrG FP Nucleotide
metabolism
Synthesis of CTP from UTP (1) Allowed the uptake of cytidine
30 37 Rv1385 pyrF FP Nucleotide
metabolism
Functions as orotidine-5’-
phosphate decarboxylase
(1) Allowed the uptake of cytidine
31 38 Rv2139 pyrD FP Nucleotide
metabolism
Functions as dihydroorotic
acid dehydrogenase
(1) Allowed the uptake of cytidine
32 39 Rv3393 iunH FP Nucleotide
metabolism
Hydrolysis of inosine (1) Let the reaction catalyzed by
ribokinase be reversible
33 40 Rv2465c rpi FP Pentose
phosphate
pathway
Functions as ribose-5-
phosphate isomerase
(1) Allowed the secretion of D-arabinose
34 41 Rv3628 ppa FP Multiple
pathways
Functions as inorganic
diphosphatase
(1) let the reaction catalyzed by
nucleoside triphosphate tripolyhydrolase
of deoxy-GTP (dGTP) to be reversible
35 42 Rv3588c Rv3588c FN Multiple
pathways
Conversion between
carboxylic acid and carbon
dioxide
(1) Blocked the ability of Rv3273 to
catalyze the same reaction
Of the 25 genes that were incorrectly predicted to be non-essential (FN) under in vivo conditions, 18 genes were corrected and became essential in the iNJ661v
network. Of the 76 genes that were incorrectly predicted to be essential (FP) under in vivo conditions, 24 genes were corrected and became non-essential in the
iNJ661v network. We classified the overall 42 (18 + 24) genes into 35 gene groups, defined as a group of genes whose products catalyze the same reaction(s).
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specificity of the iNJ661v network model were substan-
tially larger than those of the other two networks
regardless of the threshold used to determine essential-
ity. When iNJ661v was used to predict in vivo essential-
ity, we gained in our ability to classify essentiality (MCC
values of ~0.41-0.47) compared with using the in vitro
networks (MCC values of ~0.06-0.11). Thus, a signifi-
cant correlation between experimental gene essentiality
in mice and calculated mutant growth rates was only
present in iNJ661v.
We further applied threshold-independent statistical
tests to compare the abilities of iNJ661, iNJ661 m, and
iNJ661v to predict experimental gene essentiality under
in vivo conditions. Figure 6 shows the ROC curves of
the three networks. For each curve, we obtained the
95% confidence interval of the AUC (iNJ661: 0.57 ±
0.09, iNJ661m: 0.57 ± 0.09, and iNJ661v: 0.84 ± 0.06).
The AUCs of the in vitro models iNJ661m and iNJ661
were not significantly larger than those of random pre-
dictions (0.50), indicating the inability of these networks
to predict in vivo essentiality. Conversely, the AUC of
iNJ661v was significantly larger than those of the other
two networks, demonstrating that iNJ661v was better
able to predict experimental gene essentiality in mice.
After Step IV, the iNJ661v network still contained sev-
eral incorrect gene essentiality predictions. Table 4
shows the seven FN predictions that we were unable to
correct. We failed to correct the predictions for the
atpB, nirA, proV, accD1,a n dcobL genes because each
one of them is required together with one or more TN
genes. For example, the FN gene proV is required
together with the TN genes proW, proX,a n dproZ for
the transport of choline, carnitine, glycine betaine, and
proline into the cell [15]. Any “correction” of proV
would change the TN predictions for proW, proX,a n d
proZ into FP. It is likely that the gene products of proV
Table 3 Nutrient uptakes in the iNJ661v network
Uptake type Nutrients Supporting Literature (References)
Default uptakes H2O
H
+
Oxygen O2 [7,31]
Phosphorus HPO4
2-
Uptakes of small Sulphur SO4
2-
molecules Iron Fe
3+ [64]
Potassium K
+
Sodium Na
+
Nitrogen NO3
-,N H 4
+ [63]
Uptakes added in Step II Hexadecanoate,
octadecanoate,
octanoate,
dodecanoate,
arachidic acid, and
hexacosanoate
[8,28,32,52-57]
Isoleucine and
valine
[61]
cytidine and
xylose
Other necessary uptakes Glycerol [8,28,32,52-57]
Figure 6 Receiver operating characteristic (ROC) curves for
gene essentiality predictions of Mycobacterium tuberculosis.
Sensitivity [TP/(TP + FN)] and 1 minus specificity [1 - TN/(TN + FP)]
(where TP: true positive, FN: false negative, TN: true negative, and
FP: false positive) were calculated as a function of the growth ratio
thresholds used to determine gene essentiality in three different
network models: iNJ661 (dotted curve), iNJ661m (dashed curve), and
iNJ661v (solid curve).
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Page 14 of 24have other essential functions that may or may not be
related to metabolic functions and were not accounted
for in the current network description. Conversely, we
failed to correct the prediction for the Rv3534c gene
because it belongs to a pathway containing a metabolite
without a source. Thus, further studies are necessary to
discover how this metabolite is synthesized and how
this information can be incorporated into the network.
Literature Analysis and Verification
By design, our automated and systematic analysis of the
in silico/in vivo growth inconsistencies generated by the
original iNJ661m metabolic network created a network
(iNJ661v) that was more compatible with in vivo growth.
The metabolic modifications reflected how the pathogen
adjusts its metabolism to adapt to the environment that
M. tuberculosis confronts during infection in the mouse.
H e r e ,w ed i s c u s st h ep e r f o r m ed modifications vis-a-vis
the available relevant literature within the context of the
affected metabolic pathways. Table 2 shows the reviewed
literature associated with each of the performed modifi-
cations ordered by the affected pathway.
In the “glycolysis/gluconeogenesis” pathways, we
deleted the uptake of glucose from the environment and
blocked the synthesis of glucose from maltose and tre-
halose to correct the FN predictions of the Rv1099c and
ppgK genes. This modification suggested that the host
environment may lack glucose and, thus, forces M.
tuberculosis to generate glucose through gluconeogen-
esis (the pathway to synthesize glucose from the citric
acid cycle). In the “fatty acid metabolism” pathways, to
correct the FP prediction of the fabG2, inhA,a n dpks15
genes and the FN prediction of the desA3 gene, we
added the uptakes of several fatty acids from the host
environment and blocked the synthesis of a fatty acid,
hexadecenoate. This modification suggested that fatty
acids were available in the host environment and that
M. tuberculosis stopped synthesizing them under in vivo
conditions. In summary, the modifications in these two
groups of pathways, along with the retention of glycerol
uptake (see Table 3), suggested that the survival of M.
tuberculosis during infection in the mouse required
lipids (composed of fatty acids and glycerol) instead of
glucose as its primary source of carbon. The important
r o l eo fl i p i d sa sc a r b o ns o u r c e si se v i d e n tf r o mt h e
observed up-regulation of genes involved in fatty acid
catabolism during M. tuberculosis in vivo growth
[8,28,52-55], M. tuberculosis growth in dipalmitoyl phos-
phatidylcholine (a lipid present in the mammalian lung)
medium [32], the ability of the bacterium to hydrolyze
lecithin into fatty acids [8,56], and the potential role of
human serum as a highly effective fatty acid source [57].
In the pathways associated with “vitamin and cofactor
metabolism,” we removed riboflavin from the biomass
objective function to correct the FP prediction of the
ribH, ribC,a n dribD genes. The removal suggested that
riboflavin was not required for the survival of M. tuber-
culosis under in vivo conditions, which is supported by
the observation that riboflavin is used for glycolysis (the
pathway of glucose catabolism) in M. tuberculosis [58]
and that glucose is not a carbon source for the pathogen
in the host environment [8]. In the same pathways, we
also corrected the FN predictions associated with the
bioA, bioF,a n dbioB genes by adapting the biomass
objective function to include biotinyl-5’-adenosine
monophosphate (AMP) and blocked the ability of the
gene product of the bioF2 gene to catalyze the synthesis
of the precursor of biotin. Because biotinyl-5’-AMP is
Table 4 False negative (FN) predictions that could not be corrected by our network modifications
Gene
Locus
Gene
Name
Pathway Function/Reaction Reasons Why Network Modification Could Not Be Made
Rv1304 atpB Purine
metabolism
Synthesis of ATP The product of this gene catalyzes the reaction together with that of the
TN gene atpH
Rv2391 nirA Vitamin and
cofactor
metabolism
Reduction of nitrite The product of this gene catalyzes the reaction together with that of the
TN gene nirB
Rv3758c proV Transport Transport of choline, L-carnitine,
glycine betaine, and proline
The product of this gene catalyzes the transport of choline, L-carnitine,
glycine betaine, and proline together with the TN genes proZ, proW, and
proX
Rv2502c accD1 Sugar metabolism Convert propionyl-CoA into S-
methylmalonyl-CoA
The product of this gene catalyzes the reaction together with the TN gene
accA2
Rv2072c cobL Porphyrin
metabolism
Production of S-adenosyl-L-
homocysteine
The product of this gene catalyzes the synthesis of cobalamin together
with the TN genes cobK, cobM, cobH, cobN, cobI, and cobG
Rv3534c Rv3534c Pyruvate
metabolism
Convert 4-hydroxy-2-
oxopentanoate into pyruvate
In a pathway without any synthesis or uptake reaction for the metabolite
4-hydroxy-2-oxopentanoate
Rv2241 aceE Glycolysis/
gluconeogenesis
Convert pyruvate into acetyl-
CoA
Unable to determine the reason
A false negative (FN) prediction refers to a gene incorrectly predicted to be non-essential.
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nyl-5’-AMP suggests that biotin is required for the sur-
vival of M. tuberculosis under in vivo conditions. This
observation is compatible with biotin playing a role in
gluconeogenesis [60] and that M. tuberculosis obtains
glucose through gluconeogenesis under in vivo condi-
tions [8]. The blockade of BioF2 indicated that the
enzyme may be inhibited under in vivo conditions,
which is commensurate with the observed down-regula-
tion of bioF2 in the presence of hydrogen peroxide
(H2O2) [28], a reactive oxygen species that would be
encountered in an intra-phagosomal environment.
In the “amino acid metabolism” pathways, we added
u p t a k e so fi s o l e u c i n ea n dv a l i n et oc o r r e c tt h eF Pp r e -
dictions of the ilvC and ilvN genes, suggesting that
M. tuberculosis might be able to absorb these amino
acids from the host environment. Although we could
not directly verify these uptakes in M. tuberculosis,
experiments have shown that a M. tuberculosis strain
that lacks the ability to synthesize three amino acids
(valine, isoleucine, and leucine) could persist in mice for
four weeks [61]. This suggests that these amino acids
might be available, although in limited amounts, in the
host environment to compensate for the organism’s
inability to synthesize these amino acids.
We also examined the modifications with respect to
genes and reactions involved in “transport pathways.” In
this group of pathways, we added two extracellular
lipids, phthiocerol dimycocerosate A and phenol phthio-
cerol dimycocerosate, to the biomass objective function
to correct the FN prediction of the lppX gene. The bio-
mass objective function of iNJ661 and the in vivo bio-
mass objective function of GSMN-TB include
intracellular phthiocerol dimycocerosate A. In fact, these
lipids are known to be secreted by M. tuberculosis into
the environment and subsequently are associated with
the pathogen envelope, where they aid in avoiding host
immune attacks [62]. It is somewhat unusual to add
extracellular metabolites to the biomass objective func-
tion; however, given the localization of the two lipids to
the pathogen’s envelope, they can be considered as inte-
gral to the pathogen and, hence, to the biomass. More-
over, our additions of the uptakes of NO3
-,O 2, and Fe
3+
(see Table 3) were supported by the existence of NO3
-
in infected tissue [63], the detection of O2 in mouse
lung granulomas [7,31], and the ability of M. tuberculo-
sis to synthesize mycobactin, a chemical with a very
high affinity for iron, to obtain iron from the host envir-
onment [64].
The lack of detailed experimental evidence for many
modifications, as shown in Table 2, indicates that there
are currently gaps of knowledge associated with M.
tuberculosis metabolism. For example, in the transport
pathways, we corrected the FN predictions of the sugA,
sugB,a n dsugC genes by adding xylose uptake and
including xylose in the biomass objective function.
These modifications suggest that M. tuberculosis should
have a xylose utilization pathway, although this is absent
in current metabolic network descriptions of M. tuber-
culosis. The existence of such a pathway is indicated by
the experimental observation that M. tuberculosis is able
to use xylose under the presence of glycerol [65]. Con-
versely, although sequence analysis has suggested that
the sugABC operon encodes a sugar-transporting sys-
tem, it is unclear what sugar molecules the system
transports [66], suggesting that there might be other
possible reasons for the sugABC transport system to be
essential.
Growth prediction of double-deletion mutants
Double-gene deletion experiments provide insights into
redundant pathways, non-obvious coupling of metabolite
flows, and potential new drug targets. For example,
although neither the ERG11A gene nor the ERG11B
gene in Aspergillus fumigatus is individually essential,
the deletion mutant of these two genes is not viable in
immune-compromised mice, suggesting the pair of
genes as a combined drug target [67]. Large-scale
experimental double-gene deletion requires substantial
efforts, whereas the corresponding in silico simulations
of deleted gene pairs are readily available. Comparative
studies for yeast (Saccharomyces cerevisiae)h a v es h o w n
that 49% of the predicted synthetically lethal double-
deletion mutants are correct [68-70]. In silico studies of
the growth of double-deletion mutants of metabolic
genes have also been performed for E. coli [71], Helico-
bacter pylori [14], and Leishmania major [19], although
the bulk of these predictions could not be verified due
to the paucity of experimental data.
We initially examined the capability of iNJ661m and
iNJ661v to model the growth of two experimentally
examined double-gene deletion mutants. In the first
case, experimental work showed that the growth of the
ΔpanCD mutant (deletion of Rv3602c and Rv3601c)i s
highly attenuated in mice [72]. FBA of both iNJ661m
and iNJ661v predicted that ΔpanCD mutants have a
growth rate of zero, consistent with the experimental
observation. Although not confirmed experimentally,
our analysis of iNJ661m indicated that the growth
attenuation may also take place within an in vitro med-
ium. In the second case, experimental work has indi-
cated that the mutant Δicl1Δicl2 (deletion of Rv0467
and Rv1915)o fM. tuberculosis cannot survive in mice
but can grow under certain in vitro conditions [32].
FBA of iNJ661m predicted that the growth rate of
Δicl1Δicl2 was equal to that of wild-type M. tuberculosis,
whereas analysis of iNJ661v predicted that the growth
rate of Δicl1Δicl2 w a so n l y2 6 %o ft h ew i l d - t y p er a t e ,
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vivo growth.
We then performed a comprehensive FBA of iNJ661m
and iNJ661v to simulate the growth of M. tuberculosis
double-gene deletion mutants under an in vitro condi-
tion and an in vivo condition, respectively, and predicted
synthetic lethality. Additional file 1, Table S2 shows the
complete results of these calculations, and Additional
file 1, Figure S1 shows the mapping of synthetic essen-
tial gene pairs in iNJ661v to carbon metabolism-related
pathways. Figure 7 shows the number of essential gene
pairs that were uniquely and commonly predicted by
these two networks (iNJ661m and iNJ661v). The
iNJ661v network predicted a substantially larger number
of synthetically lethal genes under in vivo conditions
than the iNJ661m network under in vitro conditions.
This was partly due to the more constrained nutritional
environment faced by iNJ661v with respect to carbon
metabolism. Although drugs effective under in vitro
conditions may not be effective under in vivo conditions,
the converse may also be true [9]. The additional 131
gene pairs identified in iNJ661v indicate novel potential
drug targets under in vivo conditions. Likewise, the 35
gene pairs that were predicted to be essential under
both conditions may represent more robust drug targets
based on their insensitivity to environmental conditions.
The bulk of the 131 gene pairs uniquely predicted to
be essential for bacterial growth using iNJ661v were
related to carbon and energy metabolism. This reflects
the modifications that we implemented in iNJ661v to
reproduce the in vivo gene essentiality data in these
parts of the metabolic network. Synthetic lethality in
carbon metabolism was primarily located in the two dif-
ferent pathways that can be used to synthesize glucose
precursors from glycerol and fatty acids (as shown by
the red color in Additional file 1, Figure S1 and Table
S2). Other enzyme pairs that exhibited synthetic essenti-
ality in iNJ661v were those who catalyzed the same
reaction, i.e., each enzyme by itself was not essential,
but if they were both deleted at the same time, the reac-
tion could not proceed and the organism would stop
growing. Additional file 1, Table S2 shows that this
group includes Rv2476c, gltB, and gltD, whose gene pro-
ducts were necessary for converting a-ketoglutarate into
glutamate. An additional 76 synthetically essential gene
pairs were involved in energy metabolism. We also ana-
lyzed the 35 synthetically essential gene pairs that were
common to both iNJ661m and iNJ661v. This set was
enriched in gene pairs that were involved in amino acid
and nucleotide metabolism, supporting the suggestion
that these metabolic processes could be common drug
targets under both in vitro and in vivo conditions [34].
Figure 7 Number of essential gene pairs predicted using iNJ661m and iNJ661v. Flux balance analysis of iNJ661m under in vivo conditions
predicted 78 essential gene pairs, whereas iNJ661v predicted 166 essential gene pairs. There were 35 gene pairs predicted to be essential by
both network descriptions; 131 gene pairs were only predicted to be essential using iNJ661v, whereas 43 gene pairs were only predicted to be
essential using iNJ661 m. Most of the jointly predicted gene pairs were involved in amino acid and nucleotide metabolism.
Fang et al. BMC Systems Biology 2010, 4:160
http://www.biomedcentral.com/1752-0509/4/160
Page 17 of 24Exploration of the metabolism of M. tuberculosis using
the in vivo iNJ661v network
The gene essentiality data used to help construct the in
vivo network produced non-obvious changes in the flow
of metabolites and uptakes of nutrients from the envir-
onment. Analyses of this in vivo-compatible metabolic
network of M. tuberculosis allow us to probe the meta-
bolic state and metabolic adaptation of the pathogen to
the host environment, opening-up new avenues for tar-
geting specific enzymes or pathways that cannot be
observed under in vitro conditions. Here, we briefly
explored the M. tuberculosis metabolism as related to its
adaptation to living in an acidic environment, the
importance of the tricarboxylic acid (TCA)-cycle under
different limiting nutrient conditions, the effects of inhi-
biting multiple reactions, and the modes of cellular
respiration during infection.
The macrophage phagosome presents a generally hos-
tile environment with an acidic pH ranging from 6.2 to
4.5 [73]. The specific mechanism by which M. tubercu-
losis adapts to this acidic condition has not been fully
elucidated [74]. One well-known protective feature is
the waxy (primarily mycolic acid) cell envelope that
forms a barrier against unwanted H
+ entry [74]. In the
context of metabolism, it is speculated that the urease
reaction presents another acid adaptation mechanism by
converting H
+ and urea into NH4
+ and CO2 [75,76].
The produced NH4
+ also contributes to the M. tubercu-
losis survival by preventing the maturation of the phago-
some [77]. We used the iNJ661v network to explore
additional acid adaptation mechanisms based on the
metabolic flow of H
+. We used flux variability analysis
(FVA) to estimate the ranges of reaction fluxes in the
metabolic network at the optimal growth rate. This
allowed us to estimate the range of the overall H
+
exchange between the environment and the M. tubercu-
losis cells at the optimal growth rate for wild type
iNJ661v. The protonation state of the metabolites is
chosen to correspond to pH 7.2 [78]. Because we only
considered the steady state H
+ flux in both in vitro and
in vivo metabolic network models, the protonation
states of the metabolites were not changed in this calcu-
lation. Table 5 shows that the overall H
+ exchange was
within a narrow range of negative values, suggesting
that the in vivo metabolism consumed H
+ as a whole,
contributing to the relief of acidic stress. The primary
reaction important for this H
+ consumption was the
nitrite reductase (NR) reaction that uses H
+ and reduces
NO2
- into NH4
+. Table 5 shows that the fluxes through
NR of wild type iNJ661v were positive but did not vary,
suggesting that there must be flux through this reaction
at the optimal growth of wild type cells. Conversely, for
mutants whose NR was removed (denoted as ΔNR in
Table 5), the overall H
+ exchange could only be positive.
Given the neutralization as well as the protective effect
of creating NH4
+ [77], NR is a strong candidate for play-
ing an important function in the in vivo adaptation of
M. tuberculosis in acidic environments.
In order to more comprehensively study acid adapta-
tion/resistance we examined the role of NR in the pre-
sence of urease [75,76]. Because the iNJ661 (and the
GSMN-TB) network does not include a complete urea
synthesis pathway, we added a urea uptake in order to
create a flux through the urease reaction. Table 5
shows the estimated ranges of the H
+ exchange and
the reaction fluxes for iNJ661v with urea uptake. Over-
all, H
+ is consumed to relieve acid stress. In the wild
type strain, the flux through the NR reaction was
greater than zero, suggesting that NR still contributes
to H
+ consumption in the presence of urease. Removal
of the NR reaction (ΔNR mutant) diminished H
+ con-
sumption, but did not abolish the overall H
+ exchange.
Importantly, we performed the same analysis for the in
vitro iNJ661m network and found that the NR reaction
was always inactive, suggesting that NR does not play a
role in acid adaptation in the in vitro medium (Table 5,
last two rows). In conclusion, NR contributes to the
acid adaptation under in vivo conditions even in the
presence of other acid adaptation mechanisms. The
importance of NR in acid resistance might be experi-
mentally tested by inactivating the NR reaction and
examining cellular growth under in vivo conditions or
in vitro low-pH environments with freely available
nitrite or nitrate.
Persistence and slow growth are clinically important
states of the M. tuberculosis pathogen. Metabolic net-
work models can be used to study the metabolic states
associated with these conditions under a variety of con-
ditions that mimic slow growth. In the development of
the GSMN-TB model, Beste and co-workers induced
slow growth by limiting the uptake of glycerol and high-
lighted the corresponding changes in reaction fluxes in
the glyoxylate shunt pathway [16]. Considering that fatty
acids are the major carbon sources for in-host M. tuber-
culosis [32], here we simulated nutrient limitation to
probe slow in vivo growth by reducing fatty acid uptake.
We performed FVA to estimate the ranges of the fluxes
through the reactions in the TCA cycle and the glyoxy-
late shunt pathway under slow (reduced nutrient avail-
ability) and fast (normal nutrient availability) growth.
We simulated the slow in vivo growth by constraining
f a t t ya c i du p t a k eo fiNJ661v until the growth rate was
one third of its original value [16], and fast growth by
keeping the constraints unchanged. For each reaction
we calculated the ratio of the midpoint of the flux range
for slow growth to that for fast growth, where each flux
was normalized to the corresponding total growth rate.
This ratio represents a relative value of the fluxes and
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Page 18 of 24can be used to compare the relative importance of spe-
cific reactions.
Figure 8 shows the relevant metabolites and enzymes
and highlights the significantly decreased ratios in the
glyoxylate shunt pathway and increased reaction fluxes
in parts of the TCA cycle. The increased reaction fluxes
in iNJ661v included the 2-oxoglutarate decarboxylase
(OXGDC) and succinate-semialdehyde dehydrogenase
(SSAL) reactions, suggesting that these reactions were
likely to be important in fatty-acid-limited slow growth.
The previously suggested increased flux and importance
of isocitrate lyase (ICL) under slow-growth conditions is
a direct consequence of the glycerol limitation [16]. In
fatty-acid-limited slow growth, which is consistent with
the in vivo metabolic state, the OXGDC and SSAL reac-
tions took on a heightened function and importance in
slow-growth maintenance. The suggested metabolic
responses to fatty-acid-limited growth rate could be
experimentally tested by measuring the activities of the
enzymes in the TCA cycle of M. tuberculosis during
slow and normal growth in host environment or in an
in vitro condition infused with fatty acids as carbon
sources.
Given the ability of the metabolic network to provide
different reaction fluxes under different metabolic con-
ditions, we can explore combinations of mechanisms to
inhibit multiple reactions to derive optimal in vivo
growth-reduction strategies. Drug combinations that
achieve optimal therapeutic response and avoid side
effects caused by high doses of single drugs [79,80] can
r a p i d l yb ee x a m i n e du s i n gt h e s em o d e l i n gt e c h n i q u e s .
To illustrate this concept, we constructed an example to
investigate double-reaction inhibition using metabolic
network modeling. Given that the primary in vivo
Table 5 Flux ranges for overall hydrogen ion (H+) exchanges and other related reactions
Network Strain Overall H
+ exchange
(mmol/h/gDW)
Nitrite reductase flux
(mmol/h/gDW)
Urease flux
(mmol/h/gDW)
Min Max Min Max Min Max
iNJ661v Wild type -1.99 -1.93 1.00 1.00 0.00 0.00
ΔNR 0.04 0.07 0.00 0.00 0.00 0.00
iNJ661v Wild type -3.96 -3.90 1.00 1.00 0.99 1.00
with
urea uptake
ΔNR -1.94 -1.90 0.00 0.00 0.99 1.00
iNJ661m Wild type 2.36 3.09 0.00 0.00 0.00 0.00
ΔNR 2.36 3.09 0.00 0.00 0.00 0.00
iNJ661m Wild type 0.43 0.91 0.00 0.00 0.99 1.00
with
urea uptake
ΔNR 0.43 0.91 0.00 0.00 0.99 1.00
Overall hydrogen ion (H
+) exchange indicates the total H
+ exchange between the environment and the Mycobacterium tuberculosis cells. A negative value of the
exchange indicates that M. tuberculosis consumes H
+ as a whole, while a positive value indicates that the metabolism generate a H
+ surplus, i.e., increases
acidification of the environment. The minimum (Min) and maximum (Max) fluxes reflected the ranges of the fluxes at the optimal growth and were obtained
through flux variability analyses of iNJ661v and iNJ661 m. ΔNR represents the strain in which nitrite reductase (NR) was blocked. The unit of mmol/h/gDW
represents mmol per hour per gram dry weight of M. tuberculosis.
Figure 8 Metabolic responses of the iNJ661v network to fatty-
acid-limited growth. Metabolite flow was characterized for
enzymes in the tricarboxylic acid cycle and the glyoxylate shunt
pathway. The numbers in the graph indicate ratios of normalized
flux-range midpoints. These were calculated based on flux variability
analysis for slow and fast growth conditions, where the fluxes were
normalized by dividing by the corresponding total growth rates.
This normalization removes artifacts introduced by the lower
absolute reaction fluxes associated with induced slow growth [16].
CS, citrate synthase; ACONT, aconitase; ICDHy, isocitrate
dehydrogenase; OXGDC, 2-oxoglutarate decarboxylase; SSAL,
succinate-semialdehyde dehydrogenase; FRD, fumarate reductase;
SUCD, succinate dehydrogenase; FUM, fumarase; MDH, malate
dehydrogenase; MALS, malate synthase.
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Page 19 of 24nutrients are lipids, we focused on two reactions that
are required to process these metabolites, i.e., the gly-
cerol-3-phosphate dehydrogenase (G3PD) reaction,
which is necessary for the utilization of glycerol, and the
ICL reaction, which is a known potential drug target
and is required for the conversion of fatty acids into
other metabolites, such as pyruvate [32]. To study the
effect of this combined inhibition, we calculated growth
rates under a set of upper limits of the fluxes through
the ICL and G3PD reactions. Figure 9 shows the calcu-
lated growth rates under different upper limits for the
two reactions for both the in vivo iNJ661v (panel A) and
in vitro iNJ661m (panel B) networks.
In these graphs, the lower left hand corner corre-
sponds to the most stringent blockage of both reactions,
i.e., where the fluxes for each reaction was constrained
to be ≤10
-3 mmol/h/gDW. Figure 9A, illustrating the in
vivo results, shows that these flux limits effectively
blocked growth of the organism as indicated by the blue
color designating strongly retarded growth rates. One
can also see that whereas the ICL reaction is essential, i.
e., the organism cannot effectively grow if this reaction
is sufficiently inhibited, single blockage of the G3PD
reaction would not prevent growth if the ICL reaction
was left unconstrained (top portion of Figure 9A). It was
also clear that limiting the G3PD flux (i.e., going from
right to left in Figure 9A) further decreased the growth
rate at virtually all ICL flux values. This indicates that
for a given desired growth-rate reduction, one could use
a combination of ICL and G3PD inhibitions to achieve
the same effect as those possible with a stringent single
ICL inhibition. If these fluxes can be inhibited by drugs,
reducing the dose of the most toxic drug to achieve the
same therapeutic response would decrease risk of poten-
tial side effects. Moreover, we performed the same cal-
culation for iNJ661m and observed no combinatorial
effect of the inhibition. Figure 9B shows that when we
constrained the fluxes through the ICL and G3PD reac-
tions to zero, the growth rate was still close to that of
unconstraint growth. It is clear that the iNJ661v network
is instrumental in delineating combinatory inhibition
strategies while the in vitro iNJ661m network is not.
Finally, we examined the results of the iNJ661v double
deletion mutants with respect to cellular respiration
during infection. Additional file 1, Table S2 shows that
the genes corresponding to the cytochrome bd oxidase
(cydB-cydD and appC) and the nitrate reductase (narG-
narJ) enzymes were synthetically essential. Because these
two enzymatic groups are associated with aerobic and
anaerobic respiration, respectively, synthetic essentiality
indicates that therapy targeting cellular respiration
needs to simultaneously inhibit both aerobic and anae-
robic respiration. This conclusion is not evident from
gene expression data, which instead indicates that seven
Figure 9 Predicted effects of a double-reaction inhibition on the in vivo growth of Mycobacterium tuberculosis. The two inhibited
reactions were isocitrate lyase (ICL) and glycerol-3-phosphate dehydrogenase (G3PD). The growth rates (in units of h
-1) were calculated based
on flux balance analysis with different upper limits of the fluxes through the two reactions. The upper limits are in unit of mmol/h/gDW, i.e.,
mmol per hour per gram dry weight of M. tuberculosis. Panel A shows the results of the combinational inhibition using the iNJ661v network;
panel B shows the in vitro iNJ661m results.
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Page 20 of 24weeks post-infection the pathogen only employs nitrate
reductase enzymes for anaerobic respiration [81].
However, gene essentiality data indicate that all genes
corresponding to these enzymes (narG-narJ)a r en o n -
essential in mice, even after seven weeks [34], indicating
that anaerobic respiration is not the only available
option to the pathogen and that O2 is available to the
bacterium in the host environment [31]. Therefore, dual
inhibition of aerobic and anaerobic is necessary to fully
arrest bacterial respiration. This hypothesis can be
experimentally tested by simultaneously deleting both
gene groups and testing for differential growth of
M. tuberculosis under in vivo and in vivo conditions.
In summary, we used the developed iNJ661v network
to explore metabolism-based M. tuberculosis acid adap-
tation mechanisms, study metabolic responses to in vivo
slow growth, estimate the effects of different levels of
inhibitions of multiple reactions, and gain insights into
respiration-targeting therapy.
Discussion
Although the existing metabolic network of M. tubercu-
losis iNJ661 [15] reproduces experimentally observed
growth rates in different media and predicts gene essen-
tiality under in vitro conditions, it lacks predictive
power for in vivo gene essentiality. We developed a set
of automated procedures that systematically examined
possible metabolic modifications to the original iNJ661
network and optimized predictions of experimental in
vivo essentiality. By design, the newly developed in vivo
network iNJ661v provided significantly better agreement
(sensitivity increased from 0.31-0.44 to 0.81-0.86; Table
1) between predicted and experimental in vivo gene
essentiality.
Indirectly, the systematic reconstruction of iNJ661v
also provided a means to use high-throughput in vivo
gene essentiality data to gain insights into the in vivo
metabolism of M. tuberculosis. For example, we added
fatty acids as inputs from the host environment and
removed the ability of the network to take up glucose,
indicating that M. tuberculosis u s e sl i p i d sa st h em a j o r
carbon source for metabolism. This is compatible with
the experimentally observed upregulation of genes
involved in fatty acid catabolism [8,28,52-55]. Com-
mensurate with the aerobic nature of the organism,
our calculations indicated that O2 uptake must be
retained under in vivo conditions [7,31,82]. Another
example is our inclusion of two extracellular lipids,
phthiocerol dimycocerosate A and phenol phthiocerol
dimycocerosate, in the biomass objective function. This
is appropriate since the two secreted lipids actually
associate with the pathogen envelope to help the
organism avoid host immune attacks [62] and are thus
intimately associated with the organism/cell itself.
In addition to providing experimentally confirmed
insights, the iNJ661v network allowed us to predict a
different and putative much larger set of synthetic
double-gene deletion mutants than those obtained
under in vitro conditions. Furthermore, using iNJ661v
as a model for in vivo metabolism, we proposed that
nitrite reductase might play an important role in the
metabolic adaptation of M. tuberculosis to an acidic
environment, we found specific enzymes in the TCA-
cycle that might be important under the fatty-acid-
limiting slow-growth condition prevailing in macrophages,
we investigated combinatory inhibition of the ICL and
G3PD reactions as an effective drug-combination strategy
under in vivo nutrient conditions, and found that inhibition
of both aerobic and anaerobic respiration were required to
fully arrest cellular respiration of M. tuberculosis during
infection.
The developed methodology can provide systematic
corrections based primarily on discrepancies between
predicted and experimental gene essentiality data, which
can be used to fine-tune initial metabolic network
reconstructions. Here, we built on and expanded the
previously developed “GrowMatch” techniques of
Kumar and Maranas [39] by extending and enhancing
the possible correction steps. This was partly necessi-
tated by the more incomplete state of the M. tuberculo-
sis network compared with that of E. coli,a su s e db y
Kumar and Maranas, and the more extensive nature of
the required corrections to switch from an in vitro to an
in vivo metabolic environment. One major difference
was that our procedures included an analysis of the
combined modifications (Step III in Figure 1, with
details shown in Figure 5) to systematically eliminate
undesirable effects, e.g., very small growth rates or new
incorrect predictions of gene essentiality.
Although the gene deletion mutant growth measure-
ments used by Sassetti and Rubin [34] to experimentally
determine gene essentiality provide time-specific infor-
mation, the developed iNJ661v network did not include
a time-dependent component. In the development of
our network, a gene was considered experimentally
essential as long as it was deemed to be essential at any
time point during the entire eight-week time course
spanned by the experiments [34]. We examined this
approximation by comparing gene essentiality predic-
tions at the reported time points of one, two, four, and
eight weeks post-infection. Additional file 1, Table S3
shows a comparison of the predicted and experimental
gene essentiality at different time points, basically show-
ing that there was an overall small, non-time-specific
difference between the MCC values for the individual
time points and the time-independent value (0.47)
shown in Table 1. The sparse nature of the experimental
data did not warrant the additional complexity of
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works. However, as both the pathogen and host dynami-
cally change their responses during infection, future
work using additional datasets and modeling methodol-
ogies will be required to adequately capture this aspect
of the in vivo metabolism of M. tuberculosis.
The existence of inaccurate essentiality predictions
based on iNJ661v (FN and FP; Table 1) indicate that
there is room for further additions and corrections to
the network to better capture in vivo metabolism. The
modifications that we made to the original in vitro
iNJ661 network were relatively minor, as iNJ661v only
shows a slightly diminished capability to predict in vitro
essentiality data compared with iNJ661 m. The develop-
ment of the modified in vivo network iNJ661v was ulti-
mately based on the growth of the bacterium under
different in vitro conditions (iNJ661) and modifications
to better model experimental in vivo gene essentiality.
These conditions capture part of the pathogen’sm e t a -
bolic processes, but large knowledge gaps still exist. An
analysis of the M. tuberculosis genome indicated that
while 1,286 genes are directly associated with metabolic
processes (C. Yu, personal communication), only 663
genes were explicitly included in the developed network.
This highlights the need for further systematic theoreti-
cal analyses to improve the network description and,
more importantly, the need for experimental data under
a variety of different in vivo and in vitro growth condi-
tions that could be used to guide and validate model
development.
Higher fidelity in silico modeling of organisms pro-
vides the foundation for the eventual integration of
metabolic information with gene regulation and signal-
ing networks to model biological phenomena. Ulti-
mately, the model development presented here can be
extended to answer additional questions as they relate
to the metabolic status of the pathogen population
before, during, and after infection: What nutrients are
present in different in vivo compartments, how do they
change as infection progresses, and how do they relate
to cellular growth rates and population sizes? What is
the appropriate objective function to use for the persis-
tent dormant phase of M. tuberculosis infection? What
processes does M. tuberculosis use to handle nutrient
deficiencies and antagonistic conditions found in macro-
phages? These are the questions that we can now begin
to address using the developed iNJ661v as a more
sophisticated in vivo representation of the metabolic
network for M. tuberculosis.
Conclusion
M. tuberculosis, the causative agent of TB, continues to
pose a major health threat worldwide, with nearly two
million deaths annually. Modeling of and accounting for
the varying metabolic requirements of M. tuberculosis
during host infection can help identify the metabolic
enzymes suitable for therapeutic intervention. To this
end, we developed procedures to construct an in vivo
metabolic network model of M. tuberculosis that maxi-
mizes the agreement between predicted and measured
gene essentiality determined from infection experiments
in the mouse. We verified the modifications obtained
computationally by reviewing the available relevant lit-
erature. For example, lipids are major carbon sources
for M. tuberculosis in the host environment. The net-
work provided a metabolic description of the pathogen
consistent with the generally hostile and nutrient-poor
in vivo conditions in the host that can be exploited in
evaluation, selection, and modeling of novel potential
drug targets.
Additional material
Additional file 1: Supplementary materials. It provides the detailed
steps for constructing the iNJ661m and iNJ661v networks, and all
supplemental tables and figure.
Additional file 2: The iNJ661m metabolic network. It describes the
iNJ661m metabolic network, using the Systems Biology Markup
Language format.
Additional file 3: The iNJ661m metabolic network. It describes the
iNJ661m metabolic network, using Microsoft Excel 2003.
Additional file 4: The iNJ661v metabolic network. It describes the
iNJ661v metabolic network, using the Systems Biology Markup Language
format.
Additional file 5: The iNJ661v metabolic network. It describes the
iNJ661v metabolic network, using Microsoft Excel 2003.
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